Sector pending / Hospital and Medical Service PlansUpdated 2026-05-10 22:07 UTC

FRA/A58 stock hub

FRA/A58 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/A58is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

69.8B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/A58

In the news

Latest news · FRA/A58

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.6

P25 n/aP50 n/aP75 n/a

Trailing P/E15.3

P25 n/aP50 n/aP75 n/a

ROE12.1

P25 n/aP50 n/aP75 n/a

ROIC8.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/A58 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

208

Groups with data

Currency

USD

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	96,615
Employees Change	-7,100%
Employees Change Percent	-6.81
Enterprise value	EUR 88.7B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Hospital and Medical Service Plans
Last refreshed	2026-05-10
Market cap	EUR 69.8B
Price	EUR 316
Price currency	EUR
Rev Per Employee	1,799,107.77x
Sic	6324
Symbol	fra/A58
Website	https://www.elevancehealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.52%
EV Earnings	19.51x
EV/EBIT	13.36x
EV/EBITDA	12.02x
EV/FCF	15.86x
EV/Sales	0.52x
FCF yield	8.02%
Forward P/E	14.59x
P/B ratio	1.83x
P/E ratio	15.34x
P/S ratio	0.4x
PE Ratio10 Y	16.44x
PE Ratio3 Y	16.31x
PE Ratio5 Y	17.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.9%
EBITDA Margin	4.26%
FCF margin	3.22%
Gross margin	25.89%
Gross Profit	EUR 45B
Net Income	EUR 4.5B
Net Income Growth	-11.39%
Net Income Growth Q	-19.19%
Net Income Growth3 Y	-4.89%
Net Income Growth5 Y	2.15%
Pretax Margin	3.1%
Profit Margin	2.62%
Profit Per Employee	EUR 47,066
ROA	3.98
Roa5y	5.41
ROCE	9.71
ROE	12.09
Roe5y	15.57
ROIC	8.63
Roic5y	11.02

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-11.38%
Cagr3y	-7.69%
Cagr5y	0.82%
Div CAGR10	8.87%
Div CAGR3	5.03%
Div CAGR5	11.8%
EPS Growth	-8.15
EPS Growth Q	-16.75
EPS Growth3 Y	-2.31
EPS Growth5 Y	4.7
FCF Growth	75.56%
FCF Growth Q	399.03%
FCF Growth3 Y	-16.62%
FCF Growth5 Y	-7.75%
OCF Growth	56.9%
OCF Growth Q	325.96%
OCF Growth10 Y	7.11%
OCF Growth3 Y	-14.87%
OCF Growth5 Y	-6.56%
Revenue Growth	9.44x
Revenue Growth Q	2.64x
Revenue Growth3 Y	7.64x
Revenue Growth5 Y	9.97x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.63
Assets	EUR 109.1B
Cash	EUR 32.2B
Debt	EUR 27.6B
Debt EBITDA	EUR 3.67
Debt Equity	EUR 0.72
Debt FCF	EUR 4.94
Equity	EUR 38.2B
Interest Coverage	5.52
Liabilities	EUR 70.9B
Net Cash	EUR -19.2B
Net Cash By Market Cap	EUR -27.58
Net Debt EBITDA	EUR 2.6
Net Debt Equity	EUR 0.5
Net Debt FCF	EUR 3.44
Tangible Book Value	EUR 3.9B
Tangible Book Value Per Share	EUR 17.83

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.48
Net Working Capital	EUR 11.4B
Quick ratio	1.33
Working Capital	EUR 18.8B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	3.57%
Dividend Growth	-3.29%
Dividend Growth Years	0%
Dividend per share	EUR 5.91
Dividend Years	16
Dividend Yield	1.87%
Ex Div Date	2026-03-10
Last Dividend	EUR 1.48
Payout Frequency	Quarterly
Payout Ratio	28.97%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-11.37%
200-day SMA	278.9
3Y total return	-21.33%
50-day SMA	269.8
50-day SMA vs 200-day SMA	50under200
5Y total return	4.14%
All Time High	551
All Time High Change	-42.6%
All Time High Date	2022-11-02
All Time Low	166.1
All Time Low Change	90.47%
All Time Low Date	2020-03-24
ATR	5.03
Ch YTD	7.26
High	317.1
High52	375.4
High52 Date	2025-05-13
High52ch	-15.74%
Low	316.3
Low52	235.8
Low52 Date	2025-07-22
Low52ch	34.14%
Ma50ch	17.24%
Price vs 200-day SMA	13.4%
RSI	70.72
RSI Monthly	46
RSI Weekly	59.28
Sharpe ratio	-0.22x
Sortino ratio	-0.16
Total Return	5.44%
Tr YTD	7.9
Tr1m	13.29%
Tr1w	-0.22%
Tr3m	13.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 6.8B
Operating margin	3.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	216,661,597%
Net Borrowing	1,561,098,042
Shares Insiders	0.12%
Shares Institutions	95.56%
Shares Qo Q	-0.63%
Shares Yo Y	-3.57%
Short Ratio	2.36

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 5.4B
Average Volume	5.85x
Bv Per Share	175.2
CAPEX	EUR -1B
Ch1m	13.29
Ch1w	-0.22
Ch1y	-13.22
Ch3m	12.68
Ch3y	-25.05
Ch5y	-2.98
Ch6m	16.24
Change	-0.57%
Change From Open	-0.25
Close	318.1
Days Gap	-0.31
Dollar Volume	2,530.4
Earnings Date	2026-04-22
EBIT	EUR 6.8B
EBITDA	EUR 7.4B
EPS	EUR 20.4
F Score	6
FCF	EUR 5.6B
FCF EV Yield	6.31x
Financing CF	-2,032,951,200
Fiscal Year End	December
Founded	2,001
Goodwill	24,031,243,080
Graham Number	283.47315
Graham Upside	-10.38
Income Tax	EUR 850M
Investing CF	-2,679,089,700
Is Primary Listing	0
Last Earnings Date	2026-04-22
Last Report Date	2026-03-31
Lynch Fair Value	EUR 103
Lynch Upside	-67.41
Ma150	285.2
Ma150ch	10.9%
Ma20	290.7
Ma20ch	8.8%
Net CF	1,870,766,100
Next Earnings Date	2026-07-15
Open	317.1
P FCF Ratio	12.47
P OCF Ratio	10.58
Payment Date	2026-03-25
Position In Range	0
Ppne	3,948,959,034
Price Date	2026-05-08
Price EBITDA	EUR 9.42
Ptbv Ratio	18
Relative Volume	1.37x
Revenue	173,820,796,800x
SBC By Revenue	0.12x
Share Based Comp	216,825,000
Tax By Revenue	0.49x
Tax Rate	15.76%
Tr6m	17.55%
Volume	8

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/A58 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.9%

$5.91 annual per share

Payout ratio

+29.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+11.8%

0 consecutive years of growth

Total shareholder yield

+5.4%

Next ex-dividend date: 2026-03-10

Performance

FRA/A58 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/A58?

Insider, institutional, and short-interest positioning.

Institutional ownership

+95.6%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/A58 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

70.7

Above 70: short-term overbought

Price vs 200-day MA

+13.4%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.22

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/A58

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/A58 stock rating?

fra/A58 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/A58 analysis?

The full report lives at /stocks/fra/A58/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/A58?

The latest report frames fra/A58 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/A58 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.